SI2691083T1 - Farmacevtski sestavek sitagliptina - Google Patents
Farmacevtski sestavek sitagliptinaInfo
- Publication number
- SI2691083T1 SI2691083T1 SI201231106T SI201231106T SI2691083T1 SI 2691083 T1 SI2691083 T1 SI 2691083T1 SI 201231106 T SI201231106 T SI 201231106T SI 201231106 T SI201231106 T SI 201231106T SI 2691083 T1 SI2691083 T1 SI 2691083T1
- Authority
- SI
- Slovenia
- Prior art keywords
- sitagliptin
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI201100115 | 2011-03-29 | ||
EP12711399.1A EP2691083B1 (en) | 2011-03-29 | 2012-03-29 | Pharmaceutical composition of sitagliptin |
PCT/EP2012/055736 WO2012131005A1 (en) | 2011-03-29 | 2012-03-29 | Pharmaceutical composition of sitagliptin |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2691083T1 true SI2691083T1 (sl) | 2017-12-29 |
Family
ID=45922684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201231106T SI2691083T1 (sl) | 2011-03-29 | 2012-03-29 | Farmacevtski sestavek sitagliptina |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2691083B1 (sl) |
EA (1) | EA029539B8 (sl) |
SI (1) | SI2691083T1 (sl) |
WO (1) | WO2012131005A1 (sl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140350023A1 (en) * | 2011-12-08 | 2014-11-27 | Ranbaxy Laboratories Limited | Amorphous form of sitagliptin salts |
IN2014MU00212A (sl) * | 2014-01-21 | 2015-08-28 | Cadila Healthcare Ltd | |
PT3102187T (pt) | 2014-02-03 | 2020-06-17 | Galenicum Health Sl | Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata |
IN2014MU00651A (sl) | 2014-02-25 | 2015-10-23 | Cadila Healthcare Ltd | |
CN108144065B (zh) * | 2016-12-06 | 2023-05-16 | 江苏恒瑞医药股份有限公司 | 一种dpp-4抑制剂的药物组合物 |
MX2016016260A (es) | 2016-12-08 | 2018-06-07 | Alparis Sa De Cv | Nuevas formas solidas de sitagliptina. |
CA3081358A1 (en) * | 2017-11-10 | 2019-05-16 | Dispersol Technologies, Llc | Improved drug formulations |
EP4045048A4 (en) * | 2019-10-14 | 2023-05-24 | Santa Farma Ilaç Sanayi A.S. | ORAL FORMULATIONS COMPRISING SITAGLIPTIN HCI MONOHYDRATE WITH ENHANCED PHARMACEUTICAL CHARACTERISTICS |
EP3811930A1 (en) * | 2019-10-24 | 2021-04-28 | Authenda Pharmaceuticals AG | Oral gliptin compositions and method for preparation thereof |
GR1010089B (el) | 2020-09-15 | 2021-09-27 | Φαρματεν Α.Β.Ε.Ε. | Στερεη φαρμακοτεχνικη μορφη περιεχουσα σιταγλιπτινη και μεθοδος παρασκευης αυτης |
CN116459227B (zh) * | 2023-05-11 | 2024-07-26 | 宙晟智维生命科学(上海)有限公司 | 一种西格列汀片及其制备方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA74912C2 (en) | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
JO2625B1 (en) | 2003-06-24 | 2011-11-01 | ميرك شارب اند دوم كوربوريشن | Phosphoric acid salts of dipeptidyl betidase inhibitor 4 |
CN100457108C (zh) | 2003-09-02 | 2009-02-04 | 默克公司 | 一种二肽基肽酶iv抑制剂的磷酸盐新晶体 |
US20070021430A1 (en) | 2003-09-23 | 2007-01-25 | Chen Alex M | Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
WO2005072530A1 (en) | 2004-01-16 | 2005-08-11 | Merck & Co., Inc. | Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor |
WO2006033848A1 (en) | 2004-09-15 | 2006-03-30 | Merck & Co., Inc. | Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
EP1909776A2 (en) | 2005-07-25 | 2008-04-16 | Merck & Co., Inc. | Dodecylsulfate salt of a dipeptidyl peptidase-iv inhibitor |
KR20070111099A (ko) | 2006-05-16 | 2007-11-21 | 영진약품공업주식회사 | 시타글립틴 염산염의 신규 결정형, 이의 제조 방법과 이를포함하는 약학적 조성물 |
DE602007003024D1 (de) * | 2006-06-27 | 2009-12-10 | Sandoz Ag | Neues verfahren zur salzherstellung |
US20070172525A1 (en) * | 2007-03-15 | 2007-07-26 | Ramesh Sesha | Anti-diabetic combinations |
US20080064701A1 (en) * | 2007-04-24 | 2008-03-13 | Ramesh Sesha | Anti-diabetic combinations |
WO2009084024A2 (en) | 2007-11-02 | 2009-07-09 | Glenmark Generics Limited | A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof |
WO2009070314A2 (en) | 2007-11-26 | 2009-06-04 | Teva Pharmaceutical Industries Ltd. | Crystalline form of sitagliptin |
CA2707790C (en) | 2007-12-20 | 2015-04-21 | Dr. Reddy's Laboratories Limited | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
EP2259676A4 (en) * | 2008-03-04 | 2011-03-16 | Merck Sharp & Dohme | PHARMACEUTICAL COMPOSITIONS OF A COMBINATION OF METFORMIN AND A DIPEPTIDYL PEPTIDASE-IV INHIBITOR |
TW201000485A (en) | 2008-03-25 | 2010-01-01 | Teva Pharma | Crystalline forms of sitagliptin phosphate |
US20090247532A1 (en) | 2008-03-28 | 2009-10-01 | Mae De Ltd. | Crystalline polymorph of sitagliptin phosphate and its preparation |
PT2586782E (pt) | 2008-07-03 | 2015-02-03 | Ratiopharm Gmbh | Sais cristalinos de sitagliptina |
EP2324027B1 (en) | 2008-07-29 | 2016-02-24 | Medichem, S.A. | New crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4- triazolo[4,3-a]pyrazine derivative |
WO2010032264A2 (en) | 2008-08-27 | 2010-03-25 | Cadila Healthcare Limited | Improved process for preparation of (2r)-4-oxo-4-[3- (trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin- 7(8h)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine & new impurities in preparation thereof |
EP2218721A1 (en) | 2009-02-11 | 2010-08-18 | LEK Pharmaceuticals d.d. | Novel salts of sitagliptin |
EP2398803A2 (en) | 2009-03-30 | 2011-12-28 | Teva Pharmaceutical Industries Ltd. | Solid state forms of sitagliptin salts |
WO2010122578A2 (en) | 2009-04-20 | 2010-10-28 | Msn Laboratories Limited | Process for the preparation of sitagliptin and its intermediates |
CA2759196A1 (en) | 2009-05-11 | 2010-11-18 | Generics [Uk] Limited | Novel crystalline polymorph of sitagliptin dihydrogen phosphate |
US8415367B2 (en) * | 2010-04-08 | 2013-04-09 | Bristol-Myers Squibb Company | Pyrimidinylpiperidinyloxypyridinone analogues as GPR119 modulators |
EP2611442B1 (en) * | 2010-09-03 | 2018-07-04 | Bristol-Myers Squibb Company | Drug formulations using water soluble antioxidants |
WO2012076973A2 (en) * | 2010-12-09 | 2012-06-14 | Aurobindo Pharma Limited | Novel salts of dipeptidyl peptidase iv inhibitor |
-
2012
- 2012-03-29 EP EP12711399.1A patent/EP2691083B1/en active Active
- 2012-03-29 EA EA201391371A patent/EA029539B8/ru not_active IP Right Cessation
- 2012-03-29 SI SI201231106T patent/SI2691083T1/sl unknown
- 2012-03-29 WO PCT/EP2012/055736 patent/WO2012131005A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2691083B1 (en) | 2017-08-02 |
EA201391371A1 (ru) | 2014-02-28 |
EA029539B1 (ru) | 2018-04-30 |
EP2691083A1 (en) | 2014-02-05 |
WO2012131005A1 (en) | 2012-10-04 |
EA029539B8 (ru) | 2018-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP3864A (en) | Pharmaceutical composition | |
IL230010B (en) | Inhalable pharmaceutical ingredients | |
IL229830B (en) | Novel compinds as modulatord of gpr-119 | |
GB201113662D0 (en) | Pharmaceutical compositions | |
ZA201308208B (en) | Pharmaceutical compositions | |
LT2854768T (lt) | Pemetreksedo farmacinės kompozicijos | |
HK1199824A1 (en) | Pharmaceutical compositions | |
SI2691083T1 (sl) | Farmacevtski sestavek sitagliptina | |
GB201118232D0 (en) | Pharmaceutical composition | |
EP2702989A4 (en) | STABLE PHARMACEUTICAL COMPOSITION | |
HK1189158A1 (en) | Pharmaceutical composition | |
HRP20180567T1 (hr) | Farmaceutski pripravak omeprazola | |
EP2769718A4 (en) | MEDICINAL COMPOSITION | |
GB201118181D0 (en) | Pharmaceutical compositions | |
EP2727593A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL | |
EP2709593A4 (en) | PHARMACEUTICAL COMPOSITION OF MULTIPLE PARTICLES | |
EP2684869A4 (en) | PREPARATION OF 3-MERCAPOTOPROPIONATES | |
EP2711010A4 (en) | PHARMACEUTICAL COMPOSITION | |
HUP1100444A2 (en) | Pharmaceutical composition | |
ZA201308414B (en) | Solid pharmaceutical composition | |
EP2727594A4 (en) | NEW PHARMACEUTICAL COMPOSITION | |
HUP1100445A2 (en) | Pharmaceutical composition | |
GB201407689D0 (en) | Pharmaceutical compositions of antihypertensives | |
EP2714715A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
ZA201309537B (en) | Pharmaceutical composition comprising fexofedine |